13 Best Biotech Penny Stocks to Buy According to Hedge Funds
Peter Marks's departure from the FDA has left innovators concerned regarding the current state of the review program at the FDA. Marks had impacts on two key areas.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,380,949 | $3,880,947 | 0.04% | |
2. | Integral Health Asset Management Bhagwan Jay Rao | 2,000,000 | $3,260,000 | +12% | 0.27% |
3. | Boxer Capital Aaron Davis And Christopher Fuglesang | 1,545,000 | $2,518,350 | 0.21% | |
4. | Citadel Investment Group Ken Griffin | 1,205,537 | $1,965,025 | +573% | 0% |
5. | Millennium Management Israel Englander | 728,901 | $1,188,109 | +1265% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$5.50 | 727,272 | Large Shareholder, Director | 12,446,022 | 2024-02-08 | Filing | |
$5.50 | 727,272 | Large Shareholder, Director | 12,446,022 | 2024-02-08 | Filing | |
$5.50 | 363,637 | Large Shareholder, Director | 10,667,387 | 2024-02-08 | Filing | |
$5.50 | 727,272 | Large Shareholder | 12,446,022 | 2024-02-08 | Filing | |
$5.50 | 727,272 | Large Shareholder | 12,446,022 | 2024-02-08 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$7.26 | 1,000 | 4,541,511 | 2025-01-08 | Filing | ||
$6.71 | 164,912 | 4,542,511 | 2025-01-08 | Filing | ||
$6.50 | 25,000 | 4,707,423 | 2025-01-08 | Filing | ||
$6.11 | 100,000 | 4,732,423 | 2025-01-08 | Filing | ||
$3.89 | 150,000 | 2,698,121 | 2024-09-25 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 11,459,740 | $19,252,363 | 0% | |
2. | 10,191,476 | $17,121,679 | 0.01% | |
3. | 7,865,381 | $13,213,840 | 0% | |
4. | 2,812,500 | $4,725,000 | 0.3% | |
5. | 1,066,304 | $1,791,391 | 0% |